Better science needed to prove S-equol menopause potential
S-equol’s potential for menopause relief is ‘tantalising’ – but limited by inadequate clinical evidence, says a review into the soy-based isoflavone.
Archives for March 30, 2015
Who made the final? NutraIngredients Awards shortlist announced
NutraIngredients is pleased to announce the shortlisted finalists for the inaugural NutraIngredients Awards, with the winners announced at our exclusive awards evening in Geneva on 6th May. Will you be joining us?
Unisys wins 3-year IT contract at EFSA
Unisys Corporation has been awarded a multi-million Euro contract as part of a consortium to deliver IT services and support for the European Food Safety Authority (EFSA).
GNC deal with NYAG raises troubling issues for future of industry, observers say
A consensus is forming around the deal that GNC entered into with New York Attorney General Eric Schneiderman. The deal is being seen as good for GNC’s short term interests but bad for the future of the dietary supplement industry as a whole.
EFSA’s pledge: ‘More robust, open and transparent processes’
Greater transparency, more robust scientific assessments and wider participation are at the heart of EFSA's two-year Prometheus project.
Youngevity records strong revenue growth but stock price continues to languish
Youngevity International, a company that is both a network marketing firm that sells nutritional and personal care products and a vertically integrated gourmet coffee roaster, reported a 57% increase in annual net revnue amid plans to expand its...
Inergetics hits market with CBD powdered supplement formulated into capsules
Supplement marketer Inergetics is jumping into the CBD supplement game at what it says is a fortuitous time with the launch of new supplement branded as Nulief that will be available to start in dispensaries in the 23 states that have licensed medical...
An apple a day: It won't keep the doctor away, but might keep the pharmacist away
While an apple a day won't keep the doctor away, it could mean fewer prescription medications, say researchers.